p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular Hypertrophy
Baktybek Kojonazarov(German Center for Lung Research), Ralph T. Schermuly(Justus-Liebig-Universität Gießen)
Cited by 119
Related Papers
Reversal of experimental pulmonary hypertension by PDGF inhibition
|Journal of Clinical Investigation|2005|1.1k
Mechanisms of disease: pulmonary arterial hypertension
|Nature Reviews Cardiology|2011|778
The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats
|PLoS ONE|2012|113
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
|Nature Communications|2019|96
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
|Communications Biology|2021|15